VD's Model Portfolio & Discussion Thread Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: David Cathcart who wrote (4836)	5/7/1998 1:35:00 PM
From: Biomaven	Read Replies (1) of 9719

David, I actually did a quick Medline check at one point - there are around 2 dozen articles, if I recall correctly (most on tumors, some on zapping HIV). One that concerned me was serious-sounding neurotoxicity in hamsters - doesn't seem to have been an issue in human testing (at least that they talked about), but something that will presumably concern the FDA. (Although if they are getting even the occasional cure in pancreatic cancer, some neurotoxicity presumably wouldn't stop approval). Pretty flaky company, perennially running out of cash, with no partners that I saw. However the stock's pretty cheap for how far along they appear to be. I didn't buy any, but the stock's up quite a bit from when I passed. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next